Every SEC filing alert our engine sent, newest first: 8-K material events, deals, capital raises, leadership changes, results and insider buying and selling.
Mission Produce is hosting its 2026 Investor Day to unveil a five-year growth strategy targeting mid-single-digit organic sales growth and 300 basis points of margin expansion. The company also introduced a long-term 2035 ambition to double sales and triple Adjusted EBITDA while providing an update on its $100 million stock repurchase program.
Term
5 years
“Mission was built to lead. Over more than 40 years, we built the modern avocado category and created a platform that would be difficult to replicate. Our next chapter is about fully leveraging that platform and compounding the value we deliver to shareholders by growing faster than our markets, expanding margins, converting more earnings into cash and deploying that cash with discipline.”
John Pawlowski, President and Chief Executive Officer
Byrna Technologies reported fiscal third quarter 2026 net revenue of $15.3 million, a 46% decrease from the prior year due to lower e-commerce sales and slower dealer reorders. The company reported a net loss of $2.9 million compared to net income of $2.2 million in the same period last year, though gross margins improved to 79% (65% adjusted) driven by manufacturing efficiencies and a one-time tariff refund.
Term
Q3 2026
Earnings call
Oct 8, 2026, 9:00 AM ET
“While our third quarter revenue reflects a challenging comparison to last year's significant channel restocking, we are encouraged by the structural improvements in our business model. Our successful transition to outsourced ammunition production and the expansion of our adjusted gross margins demonstrate our commitment to operational efficiency and long-term profitability as we continue to scale the Byrna brand through new influencer and media partnerships.”
AquaBounty Technologies entered into agreements with holders of its Series A and Series B Preferred Stock to automatically convert all outstanding preferred shares into approximately 8.08 million shares of common stock. The conversion is expected to occur by October 30, 2026, at which point the preferred shares will be cancelled and retired. The company has also agreed to file a registration statement to facilitate the resale of these newly issued common shares.
NextTrip reported initial global viewing metrics for its JOURNY TV platform, generating over 307 million viewing minutes from January through August 2026. Following an advertising operations transition in July 2026, the company saw a 668% increase in average monthly Samsung U.S. programmatic advertising revenue and projects full-year 2026 revenue for that segment to nearly double year-over-year.
Dragonfly Energy Holdings Corp. has announced a 1-for-8 reverse stock split of its common stock, effective October 12, 2026. The split is intended to increase the bid price of the company's shares to regain compliance with Nasdaq's $1.00 minimum bid price requirement. No fractional shares will be issued; instead, stockholders will receive one whole share in lieu of any fractional interest.
NOVAGOLD reported a net loss of $36.0 million, or $0.08 per share, for the third fiscal quarter ended August 31, 2026. The company maintained a strong treasury with $343.4 million in cash and term deposits to fund the ongoing Bankable Feasibility Study for the Donlin Gold project. Results were impacted by elevated professional fees related to the pending acquisition of Paulson's 40% interest in Donlin Gold.
DiamondRock Hospitality Signs $31M M&A Deal with The Bellmoor Inn & Spa
DiamondRock Hospitality Company completed the acquisition of The Bellmoor Inn & Spa, a 79-room luxury resort in Rehoboth Beach, Delaware, for $31.0 million. The acquisition price represents a 10.4x Hotel EBITDA multiple and an 8.6% capitalization rate based on trailing twelve-month results. The company plans to implement asset management initiatives and off-season capital improvements to reach a projected stabilized NOI yield of 9.5%.
Hyperfine reported preliminary unaudited third quarter 2026 revenue of approximately $6.0 million, representing 53% sequential growth. The company also reported estimated cash and cash equivalents of $37.9 million and reaffirmed its full-year 2026 revenue guidance of $20 million to $22 million.
Virginia National Bankshares Announces $18.7M Stock Buyback
Virginia National Bankshares Corporation has authorized a new share repurchase plan to buy back up to $18.7 million of its common stock. The program is authorized to run through October 5, 2027, and allows for repurchases in the open market or through private transactions. This plan signals management's commitment to returning capital to shareholders based on market conditions and corporate needs.
AngioDynamics reported fiscal first quarter 2027 net sales of $80.9 million, representing 6.9% year-over-year growth driven by its Med Tech segment. The company achieved a GAAP gross margin of 59.4% and an adjusted EBITDA of $5.0 million. Additionally, the company announced that Eric Honroth will succeed Jim Clemmer as President and CEO effective November 2, 2026.
Term
Q1 2027
“Our first quarter results reflect the continued, consistent execution we’ve built into this business. Med Tech again led our growth, highlighted by Auryon’s 21st consecutive quarter of double-digit atherectomy growth, continued performance in Mechanical Thrombectomy, and ongoing strength in our NanoKnife oncology platform.”
Jim Clemmer, President and Chief Executive Officer
“As I shared previously, after ten years leading this company, I have decided to retire, and the Board has completed a comprehensive search for my successor. I’m pleased to share that Eric Honroth will become our next President and Chief Executive Officer.”
Jim Clemmer, President and Chief Executive Officer
AngioDynamics appointed Eric Honroth as President and Chief Executive Officer, effective November 2, 2026, succeeding the retiring James C. Clemmer. Honroth's employment agreement includes an annual base salary of $735,000, a target annual bonus of 95% of base salary, and eligibility for long-term incentive awards under the company's equity plan.
Crescent Energy Signs $4.22B M&A Deal with Devon Energy Production Company, L.P.
Crescent Energy has entered into a definitive agreement to acquire Eagle Ford assets from Devon Energy for $4.22 billion in cash. The acquisition adds approximately 68 Mboe/d of net production and over 600 Tier 1 drilling locations adjacent to Crescent's existing operations. The deal is expected to close in late 2026 or early 2027 and includes $140 million in identified annual synergies.
Value
$4.22B
Counterparty
Devon Energy Production Company, L.P.
Earnings call
Oct 8, 2026, 8:00 AM ET
“This acquisition represents a significant step forward for Crescent, adding high-quality assets at an attractive valuation in the heart of one of our core operating areas. We know these assets exceptionally well through our longstanding minerals ownership and nearby operations, and see meaningful opportunity to make them even better. The transaction solidifies Crescent’s world-class Eagle Ford position and creates significant additional value creation opportunities through our proven operating strategy.”
David Rockecharlie, Chief Executive Officer of Crescent Energy
Shoulder Innovations announced the limited user release and commercial launch of InSet Go, its next-generation glenoid implant for anatomic shoulder arthroplasty. The launch follows the successful completion of the first surgical case and aims to improve procedural efficiency while maintaining the company's clinically-proven design for implant stability.
Editas Medicine received approval to initiate its Phase 1/2 Strive clinical trial for EDIT-401 in Australia, targeting patients with heterozygous familial hypercholesterolemia. The company expects to begin patient dosing in 2026 and report initial safety and tolerability data in the first quarter of 2027. Additionally, the company will present new preclinical data demonstrating durable LDL-C reduction at the AHA Scientific Sessions in November 2026.
Tetra Technologies Debt Financing Update with Silver Point Finance, LLC
TETRA Technologies entered into a first amendment to its term loan credit agreement with Silver Point Finance to improve borrowing terms. The amendment reduces the interest rate from SOFR + 5.75% to SOFR + 5.00%, extends the maturity date to December 31, 2030, and defers quarterly amortization payments until June 2028.
Tilray Brands reported record Q1 fiscal 2027 net revenue of $257.1 million, a 23% increase year-over-year, driven by double-digit growth in international cannabis, beverage, and pharmaceutical distribution. The company expanded its gross margin to 30% and reduced its outstanding debt by $42 million fiscal year-to-date, ending the quarter in a net cash position.
Term
Q1 2027
“Tilray’s record first-quarter revenue and gross profit demonstrate the power of the diversified platform we have built and the momentum we are creating across cannabis, beverage, hospitality, wellness and pharmaceutical distribution. We are no longer dependent on a single market or regulatory catalyst. We have multiple engines of growth, a scaled international footprint and the ability to convert scale into stronger margins, greater efficiency and sustainable, profitable growth.”
Irwin D. Simon, Chairman and Chief Executive Officer, Tilray Brands
“Our global platform is translating into leadership positions across our core categories. In cannabis, Tilray is a leading cannabis producer, with more than 6 million square feet of cultivation capacity across Canada, Portugal and Germany, and a leading low-cost production base in the world’s largest legally regulated markets, supported by one of the largest EU-GMP certified footprints in the world.”
Irwin D. Simon, Chairman and Chief Executive Officer, Tilray Brands
Henry Schein appointed Emmanuel Caprais as Senior Vice President and CFO, effective November 4, 2026, succeeding Ronald N. South who will transition to a Senior Advisor role. Caprais will receive an annual base salary of $750,000, a target bonus of $750,000, and a 2027 long-term incentive award estimated at $2.5 million.
Kathryn Rowen, Executive Vice President and Chief Transformation and Operations Officer, notified Vontier Corporation of her decision to resign effective October 16, 2026. Her departure is to pursue another opportunity, and no successor was named in the filing.
Atrium Therapeutics entered into a securities purchase agreement for a $50 million private placement (PIPE) involving the sale of 5,170,384 common shares and pre-funded warrants for 1,134,930 shares. The offering was priced at $7.93 per share and included participation from several institutional investors. Proceeds will be used to fund the development of lead product candidates and extend the company's cash runway through 2028.
Value
$50M
Counterparty
Sirenia Capital Management LP, Aberdeen Investments, Montanova, Sessa Capital, Casdin Capital
The ICC International Court of Arbitration issued a partial final award finding that Venture Global breached its obligation to timely declare the commercial operation date (COD) of the Calcasieu Project under its SPA with Galp Trading S.A. While a separate damages hearing is expected in 2027 or 2028, any final award will be subject to a $170 million seller aggregate liability cap. Venture Global expressed disappointment, noting the ruling contradicts prior arbitration findings involving Shell and Repsol.
Helen of Troy reported second quarter fiscal 2027 results with consolidated net sales growth of 2.1% to $440.9 million and GAAP net income of $4.6 million. The company raised its full-year fiscal 2027 outlook for GAAP diluted EPS, Adjusted EBITDA, and free cash flow while narrowing its net sales guidance range.
Term
Q2 2027
Earnings call
Oct 8, 2026, 9:00 AM ET
“Our second quarter results reflect continued progress against our multi-year roadmap. Sales were in line, and Adjusted EBITDA and Adjusted EPS were better than expected, without including the net tariff refund benefit in the quarter. Sales growth was broad-based across Home & Outdoor, Wellness, and International, with improving fundamentals across the balance of the portfolio. We also continued to strengthen our balance sheet, generate free cash flow, and focus resources on the opportunities with the greatest potential to create value.”
G. Scott Uzzell, Chief Executive Officer
“While there is still meaningful work ahead, we are encouraged by the progress we are making to build a Better Helen of Troy on the road to becoming a Bigger Helen of Troy. We plan to continue making targeted investments in our brands, capabilities, and organization, including reinvesting the vast majority of tariff refunds, while allowing a portion to support near-term earnings and liquidity.”
Nova Minerals Capacity Expansion: $43.4M Investment
Nova Minerals has received all key plant equipment at Port MacKenzie, Alaska, to begin construction of its antimony processing and refinery facility. The project aims to establish a vertically integrated U.S. domestic antimony supply chain and is supported by a $43.4 million award from the U.S. Department of War.
51Talk Online Education Group CEO Jack Jiajia Huang Buys $32.3M of Stock
Jack Jiajia Huang, CEO, bought 2,812,140 shares of 51Talk Online Education Group at $11.48 to $11.50 a share (average $11.50) in 6 transactions, worth $32.3M in total between Sep 17, 2026 and Sep 25, 2026. Shares held after the trade: 38,427,300 (+3.3%).
Frequency Electronics held its Annual Meeting of Stockholders on October 7, 2026, where shareholders elected five directors to one-year terms. Stockholders also ratified Grant Thornton LLP as the independent auditor for fiscal year 2027 and approved executive compensation on a non-binding advisory basis.
Perspective Therapeutics announced that the FDA has granted Fast Track Designation for PSV359, an investigational FAP-targeted alpha-particle therapy. The designation is for the treatment of adult patients with locally advanced unresectable and/or metastatic fibroblast activation protein-positive solitary fibrous tumors (SFTs).
Drilling Tools International Signs $81M M&A Deal with Saltire Energy Limited & Foxley Energy Limited
Drilling Tools International (DTI) entered into a definitive agreement to acquire Saltire Energy Limited and Foxley Energy Limited for approximately $81 million in cash and 17.4 million shares of common stock. The acquisition significantly expands DTI's international presence, increasing its Eastern Hemisphere revenue contribution from 18% to approximately 40%. The transaction is expected to close in the first quarter of 2027 and be immediately accretive to key financial metrics.
Haemonetics provided a status update on its non-exclusive supply agreement with CSL Plasma, noting that CSL expects to complete the rollout of NexSys PCS devices and Persona PLUS disposables across all its U.S. collection centers by the end of 2027. The company maintained its existing fiscal 2027 guidance and plans to provide a detailed financial impact update during its November 2026 earnings call.
Prudential Financial's Japanese subsidiary, Prudential Life Insurance Co., Ltd., published the findings of a Special Investigation Committee (SIC) report regarding previously disclosed misconduct by sales employees. The report identified structural problems in the company's management framework, business model, and organizational culture that allowed inappropriate monetary conduct to persist. The company is implementing structural reforms, including changes to compensation systems and sales management, to prevent recurrence and ensure customer-centric operations.
New ERA Energy & Digital $116M Debt Financing with Macquarie Bank Limited
New Era Energy & Digital's subsidiaries entered into a $116.0 million Letter of Credit Reimbursement Agreement with Macquarie Bank Limited to provide credit support for a Power Purchase Agreement with Luminant. The facility is secured by $118.3 million in cash collateral, partially funded by a $60.0 million drawdown from an existing term loan which also triggered the issuance of 413,055 warrants to the lender.
The Brink's Company announced that the UK Competition and Markets Authority (CMA) has accepted in principle its proposed remedy to divest NoteMachine/TestLink UK to address antitrust concerns. This regulatory progress allows the pending acquisition of NCR Atleos to remain on track for an expected close in early Q1 2027. Brink's reaffirmed its expectation of $200 million in annual run-rate cost synergies despite the required divestiture.